RHEUMATOLOGY BILLING

Rheumatology Billing Services

Rheumatology billing centers on infusions and injectable biologics, where drug units, administration codes and prior authorizations drive reimbursement.

No upfront feesHIPAA-compliantSpecialty-trained coders
$0

Upfront or setup fees

9

Revenue cycle steps managed end to end

37

Specialties and lab types we bill for

100

Of your data and systems stay yours

OVERVIEW

Rheumatology billing done right

Rheumatology billing centers on infusions and injectable biologics. Infliximab, abatacept, tocilizumab and their biosimilars are expensive, tightly managed by payers and billed with administration codes that depend on the drug and the documented infusion times.

Payers require prior authorization, step therapy, preferred biosimilars and sometimes a specific site of care. Joint injections, aspirations and ultrasound guidance add their own bundling and documentation rules.

We handle rheumatology billing from authorization to payment: confirming the preferred product, securing approval, coding the administration and drug correctly, and appealing denials with the clinical history payers ask for.

Also see our medical coding, denial management, eligibility verification and revenue cycle management services.

CODING

Common rheumatology CPT & HCPCS codes we bill

Rheumatology claims mix drug administration, drugs, joint procedures and imaging.

CodeDescriptionWhat we watch for
96413Complex drug administration, IV infusion, up to 1 hourUsed for many biologic infusions such as infliximab, per payer policy.
96365Therapeutic IV infusion, initial, up to 1 hourFor infusions that do not meet the complex drug administration criteria.
96372Therapeutic injection, subcutaneous or intramuscularFor in-office injections of biologics and corticosteroids.
J1745Injection, infliximab, excludes biosimilar, 10 mgMany plans require a biosimilar first; billing the wrong product is a common denial.
Q5103Injection, infliximab-dyyb, biosimilar, 10 mgEach biosimilar has its own Q-code; units are per 10 mg.
J0129Injection, abatacept, 10 mgIV doses are weight based; units must match the dose given.
J3262Injection, tocilizumab, 1 mgDose and frequency are checked against the approved authorization.
20610Arthrocentesis, aspiration or injection, major joint, without ultrasound guidanceUse 20611 when ultrasound guidance is used and documented with images.
J1030Injection, methylprednisolone acetate, 40 mgBill the drug with the joint injection procedure.
77080DXA bone density study, axial skeletonMedicare covers repeat studies at set intervals based on risk.

Code descriptions are summarized. CPT® is a registered trademark of the American Medical Association. Coverage and payment rules vary by payer and change every year; we code to the current code set and your payers’ policies.

Modifiers that matter in rheumatology billing

JW / JZ

Drug wasteReport discarded drug, or none discarded, on single-dose vial drugs.

RT / LT

Right and left sideIdentify the joint injected; use both for bilateral injections per payer rules.

25

Significant, separate E/MFor a visit that goes beyond the decision to inject a joint.

59 / XS

Separate structureFor injections into different joints when NCCI pairs the codes.

DENIALS

Why rheumatology claims get denied

The denial reasons we see most often in rheumatology billing, with the claim adjustment reason code (CARC) payers usually attach, and what we do so they don't happen again.

CO-197

No authorization for the biologic

Biologics are almost always on prior authorization lists, with renewals every 6 to 12 months.

How we prevent it: We track every patient’s authorization and renew before it expires.

CO-50

Step therapy not met

Payers require documented failure of conventional DMARDs before approving a biologic.

How we prevent it: We include prior treatments, dates and outcomes in every authorization and appeal.

CO-16

Wrong product or missing NDC

Billing the reference product when the plan requires a biosimilar, or omitting the NDC, stops payment.

How we prevent it: We confirm the preferred product and include NDCs on every drug line.

CO-97

Ultrasound guidance or E/M bundled

Ultrasound guidance billed separately with 20611, or a visit without modifier 25, is bundled.

How we prevent it: We use the guided injection code and add 25 only when the visit is separately documented.

CO-151

Dose or frequency over the approved amount

Units or dosing intervals above the authorization are denied.

How we prevent it: We compare each claim to the approved dose, units and interval before submission.

HOW WE WORK

How we run your rheumatology revenue cycle

From the first eligibility check to the final patient payment, one dedicated team handles every step and reports back to you.

01

Eligibility and authorization

We verify coverage, benefits, copays and deductibles before the visit. For rheumatology, that includes biologic authorizations, step therapy documentation and site-of-care rules.

02

Charge capture and coding

Our coders review documentation and assign CPT, HCPCS and ICD-10-CM codes to the highest supported specificity. Infusion times, drug units and joint procedures are coded from the infusion record and notes.

03

Claim scrubbing and submission

Every claim is checked against NCCI edits, payer policies and modifier rules before it goes out electronically, so it is paid on the first pass.

04

Payment posting and reconciliation

We post ERAs and EOBs, compare payments to your contracted rates and flag underpayments for appeal.

05

Denial management and A/R follow-up

Every denial is worked: corrected, appealed or escalated, with root causes fed back to the front end. Biologic denials are appealed with prior treatment history and disease activity scores.

06

Reporting and patient billing

You get clear monthly reports on collections, denials and A/R aging, and patients get easy-to-read statements and answers to billing questions.

COMPLIANCE

Rheumatology payer rules we track for you

Rules that change how rheumatology claims must be coded, documented and submitted.

Biosimilar policies: many plans require a specific biosimilar and deny the reference product.

Site of care: some payers move infusions from hospital outpatient to office or home infusion.

Buy-and-bill versus specialty pharmacy: the drug may be billed by the practice or supplied by a specialty pharmacy.

Imaging guidance: ultrasound-guided joint injections need permanently recorded images and a report.

FAQ

Rheumatology billing questions

Do you handle biologic prior authorizations?
Yes. We submit initial authorizations and renewals with step therapy history and disease activity documentation.
Can you tell us which biosimilar a plan prefers?
Yes. We check each payer’s preferred product before the first infusion so the right drug is ordered and billed.
Do you bill in-office infusion suites?
Yes. We bill drug administration and drugs for in-office infusion suites, including waste reporting and NDCs.
How much do your rheumatology billing services cost?
We charge just 2.25%–2.75% of what we actually collect for you, with no upfront or setup fees. Your exact rate within that range depends on claim volume and the services you need, and we confirm it after a free review of your current billing.
Do we have to change our EHR or practice management system?
No. We work inside the systems you already use, and your data stays yours. We set up secure access, learn your workflows and start working claims without disrupting your front desk.

Related specialties

FREE RHEUMATOLOGY BILLING REVIEW
Get Paid

Send us a sample of your rheumatology denials and A/R. We'll show you where revenue is slipping and how we'd fix it, with no obligation and no upfront fees.

Call NowFree Consultation